Search results
Some U.S. Weapons Stymied by Russian Jamming in Ukraine
New York Times· 6 days agoTwo classified Ukrainian reports show that some U.S. precision-guided weapons are vulnerable to...
New list rates the most bipartisan members of Congress — and the least
Maryland Matters via Yahoo News· 3 days agoWith the exception of Reps. David Trone (D-6th) and Dutch Ruppersberger (D-2nd), most members of...
The media bosses fighting back against AI — and the ones cutting deals
Washington Post via Yahoo News· 4 days agoA little more than a year ago, Barry Diller rallied his fellow media titans to fight artificial...
US intelligence agencies' embrace of generative AI is at once wary and urgent
seattlepi.com· 7 days agoLong before generative AI's boom, a Silicon Valley firm contracted to collect and analyze...
Cleveland Fed taps former Goldman executive Hammack for president's job By Reuters
Investing.com· 2 days agoNEW YORK (Reuters) -Former high-ranking Goldman Sachs executive Beth Hammack will become the next...
Healthcare rethinks cybersecurity staffing as threats rise
Crain's Cleveland Business· 3 days agoIn 2023, a record 133 million individuals were potentially affected by healthcare data breaches, according to the Health and Human Services Department's Office for Civil Rights ...
Greg Fergus' rocky road
Politico· 2 days agoDuring the past three decades, Canada has issued four export permits — in 2008, 2010, 2015 and 2018 — for small arms, such as pistols and rifles. — Tall...
Analysis | Will covid be on anyone’s radar this summer?
Washington Post· 3 days agoCongress is in recess this week, but your friends at the Health Brief are here for you. Today’s...
AI career coaches are here. Should you trust them?
Washington Post· 2 days agoArtificial intelligence tools can spit out basic code, construct legal arguments and even illustrate children’s books. A new crop of chatbots is tackling...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 12 hours agoAdaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next generation MAGE-A4 TCR T-cell therapy) produced on Galapagos’ decentralized manufacturing platform in patients with head
